Aptevo Therapeutics Inc.
APVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671584
No open-market purchases or sales by Aptevo Therapeutics Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $224.3K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Aptevo Therapeutics Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 34 | 29 | −5 |
| Shares | 2.94M | 2.92M | −22.0K (−0.7%) |
| Value | $89.7M | $65.5M | −$24.2M (−27.0%) |
New holders (6)
Institutions that held Aptevo Therapeutics Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kennedy Capital Management, Inc. | 187,995 | $4.22M | 0.09% |
| Verition Fund Management LLC | 15,000 | $336.0K | 0.00% |
| State Street Corp | 10,973 | $246.0K | 0.00% |
| UBS Group AG | 1,821 | $41.0K | 0.00% |
| IFP Advisors, Inc | 218 | $5.00K | 0.00% |
| Citigroup Inc | 10 | $0 | 0.00% |
Sold out (11)
Institutions that held Aptevo Therapeutics Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Ghost Tree Capital, LLC | 50,000 | $1.53M |
| Two Sigma Investments, LP | 39,509 | $1.21M |
| Stonepine Capital Management, LLC | 38,593 | $1.18M |
| Two Sigma Advisers, LP | 30,400 | $928.0K |
| Bank of Montreal | 25,280 | $674.0K |
| Bank of New York Mellon Corp | 9,964 | $305.0K |
| Schonfeld Strategic Advisors LLC | 9,700 | $296.0K |
| Marshall Wace, LLP | 7,991 | $244.0K |
| Teachers Retirement System of the State of Kentucky | 400 | $12.0K |
| Tower Research Capital LLC (TRC) | 140 | $4.00K |
| Sowell Financial Services LLC | 24 | $1.00K |